Maternal Zika Lessons for Australia's Perinatal Networks

Maternal Zika virus surveillance is most useful when it follows an exposure through pregnancy, childbirth and early infancy. A positive test in a non-pregnant adult matters, but a pregnant patient’s travel history, gestational timing, partner exposure and fetal findings require a different response. Networks built only around laboratory notifications can miss the people whose outcomes matter most.

Pregnant patients are often asymptomatic, and congenital Zika syndrome can include growth restriction, eye abnormalities, neurological injury and neonatal death. Ultrasound may initially appear normal, so a single reassuring scan cannot close the case. Surveillance must connect laboratory evidence with serial obstetric review and postnatal follow-up.

For Australia, the challenge is a shifting border between imported infection and local transmission. Smartraveller advice, overseas travel, dengue and chikungunya diagnoses, and mosquito activity around Brisbane, Cairns, Townsville and Darwin all shape the risk picture. The system should remain alert without implying that every traveller to an affected area faces the same danger.

A practical response is a national surveillance spine that supports state and territory teams rather than replacing them. It should capture pregnancy-specific exposures, use consistent laboratory interpretation, link maternal and infant outcomes, and trigger public-health action within days. The lessons from regional perinatal collaboration can make that network usable during an outbreak, during routine practice and after an event has passed.

Why pregnancy exposure needs separate surveillance

Pregnancy-focused surveillance starts with a different unit of concern: the mother-infant dyad. That approach recognises that infection around conception or in the first trimester carries the greatest risk of fetal harm, while later infection can still require assessment. It also asks clinicians to record negative findings, including serial ultrasound and postnatal examination, so absence of notification does not masquerade as absence of risk.

These layers answer different questions and should be joined rather than ranked. Travel alerts may trigger testing before symptoms appear. Laboratory records establish what was detected, while mosquito data indicate whether local acquisition is plausible. Pregnancy records establish clinical significance, and the infant registry shows whether surveillance translated into earlier care. Any one layer would distort the response if used alone.

The former FAOPS 2020 meeting illustrates the value of cross-border scientific exchange, even though the planned Tokyo congress was cancelled as COVID-19 disrupted international travel. For Zika, the same regional outlook should connect Australian expertise with Pacific and South-East Asian networks, shared diagnostic protocols and coordinated risk communication. A resilient surveillance system must work when conferences or travel stop, which is now a familiar lesson from 2020.

Tracking travel, vectors and community transmission

Travel history should be recorded at antenatal booking and revisited whenever a patient develops fever, rash, joint pain or conjunctivitis. Australian clinicians can consult Smartraveller and federal Zika guidance, including advice for pregnancy. Sydney and Melbourne receive many international arrivals, while Brisbane and Cairns are operationally important gateways for northern Australia; each requires a consistent questioning and referral pathway.

Local risk depends on Aedes aegypti and Aedes albopictus activity, especially through the warm, wet season in northern Queensland and the Northern Territory. Council vector-control teams in places such as Townsville and Darwin, together with Queensland’s statewide surveillance, can connect mosquito trapping to public-health alerts. Customs biosecurity controls on soil, plants and containers reduce the chance of transporting mosquito eggs, but they cannot substitute for larval control and community education.

Sexual transmission adds a pathway that travel records alone will miss. Services should ask about symptomatic or exposed partners without making blame the centre of the conversation, offer testing, and discuss condom use and a period of abstinence according to current national guidance. Perinatal networks already organise rapid responses to obstetric hazards, and a FAOPS account of uterotonics and interventional radiology illustrates how specialist knowledge can be translated into care pathways for postpartum haemorrhage. Zika surveillance can use comparable escalation channels so maternal deterioration, fetal findings and neonatal care remain connected.

Building a linked pregnancy and infant registry

A linked registry needs a compact dataset that teams can complete under real clinical pressure. For each exposed or infected pregnancy, it should record the trimester at exposure, travel and partner exposure, symptoms, laboratory specimen dates, mosquito-acquisition assessment, ultrasound findings, delivery data and neonatal assessment. Standardised categories make data comparable, while free-text notes should retain clinical nuance without becoming the only searchable field.

In Australia, public maternity units, private obstetric practices, midwives, general practitioners and pathology providers may all contribute. The network should preserve state and territory responsibility for notifiable disease while supporting consistent national coding, secure identifiers and agreed data-sharing. Public maternity care, Medicare-funded services and local child health teams provide several routes for follow-up, yet linkage must not depend on one billing platform or exclude families who move between jurisdictions.

People with lived experience should help define follow-up, language access and acceptable contact methods, particularly in regional and remote communities. This is especially important for Aboriginal and Torres Strait Islander communities, where community-controlled reporting and appropriate data governance are central to safe surveillance design. Public communication should be tested with communities rather than copied from an overseas campaign. The concise, discussion-led format associated with Youth Bath TEDx offers a useful model for turning specialist evidence into messages that non-specialists can understand and discuss without sensationalising the risk.

Making diagnoses and outcomes measurable

Diagnostic algorithms must combine timing, symptoms and test purpose. Zika reverse-transcription polymerase chain reaction can be useful early, while serology requires specialist interpretation because dengue and other flavivirus antibodies may cross-react. The local market for laboratory testing includes national reference providers, private pathology companies and regional hospital laboratories, with accreditation, availability and turnaround times that differ by location. Australian laboratories should therefore share specimen dates, assay details and confirmatory results, with a named reference contact for pregnancy-associated cases.

Quality assurance extends beyond the laboratory. A clinical review of post-transplant respiratory syndrome shows why registries need clear event definitions and long-term outcome fields when infection or treatment interacts with underlying disease. The Zika model can adapt that discipline by recording maternal complications, congenital findings, infant growth, hearing and eye assessment, and neurodevelopmental milestones at agreed intervals.

Outcome review must also account for stillbirth, neonatal death, prematurity and clinical decisions influenced by infection. A congenital Zika syndrome label should never replace a fuller description of the child’s diagnosis and support needs. Teams should audit whether exposed infants received appropriate imaging, ophthalmological examination, hearing assessment and developmental review, and whether families received the results in understandable language.

Turning surveillance into coordinated action

Surveillance becomes actionable when predefined thresholds lead to named responses. A single confirmed infection in a pregnant patient may trigger case management and partner assessment; clusters of infections or evidence of local transmission may add vector control, broader testing and public alerts. Thresholds should be locally adjustable, and every alert should specify who acts, what information they receive, how quickly they must respond and how the decision is documented. These pathways must also operate across borders because Zika events move through travel, trade and family networks.

Regular exercises can test the seams between public health, antenatal services, laboratories and child health teams. A scenario could begin with a returning traveller from the Pacific presenting in Melbourne, another case involving unexplained congenital features in Cairns, and a third detected through sexual-health screening in Perth. The exercise should reveal missing laboratory access, inconsistent travel questions or follow-up letters sent to former addresses, then assign corrections before a genuine event exposes them. Australian teams can share protocols with Pacific and Asian partners and align traveller advice without delaying domestic action, because local vector conditions, health-system capacity and access routes differ.

The immediate call to action is to build a small, nationally agreed pregnancy-exposure record and connect it to existing maternal, neonatal and notifiable-disease systems. Each state and territory health department should nominate a clinical and laboratory contact, agree a minimum dataset with perinatal services, and test the notification pathway through one desktop exercise and one patient-level review. Existing national bodies can coordinate the specification while local teams retain authority for immediate public-health action.

Institutions can support the network now by sharing de-identified outcome data, standardising ultrasound and infant follow-up fields, and publishing plain-language advice for pregnant travellers and partners. Clinicians can complete exposure and testing prompts at antenatal booking and refer suspected infection without waiting for a national alert. The result will be a perinatal surveillance network capable of seeing maternal Zika risk early, acting quickly and learning from every exposed pregnancy and infant.